Omnia Family Wealth’s Halozyme HALO Stock Holding History

Omnia Family Wealth’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,144	Closed	-$18K	–	275
2019 Q1	$18K	Hold	1,144	–	–	0.01%	220
2018 Q4	$17K	Hold	1,144	–	–	0.01%	209
2018 Q3	$21K	Sell	1,144 -556	-33%	-$9.74K	0.01%	202
2018 Q2	$29K	Buy	+1,700	New	+$32.1K	0.01%	188
2017 Q4	–	Sell	-300	Closed	-$5K	–	616
2017 Q3	$5K	Buy	+300	New	+$4.06K	﹤0.01%	340

Other funds holding HALO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Omnia Family Wealth's HALO Position: Q2 2019 in Review

Omnia Family Wealth sold out of Halozyme (HALO) in Q2 2019, closing a stake of 1,144 shares — an estimated $18K sold.

Omnia Family Wealth first reported a position in HALO in Q3 2017 and held it in 5 quarters. The position peaked at $29K in Q2 2018. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

Omnia Family Wealth reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
Omnia Family Wealth sold 1,144 Halozyme shares in Q2 2019, an estimated $18K.
Omnia Family Wealth first reported a position in Halozyme in Q3 2017 and held it in 5 quarters.
Omnia Family Wealth's Halozyme position peaked at $29K in Q2 2018.
202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on Omnia Family Wealth's 13F filing for Q2 2019, filed 7 Aug 2019.